TrinityBridge Ltd Purchases Shares of 30,729 ChronoScale Corporation Common Stock $CHRN

TrinityBridge Ltd acquired a new position in shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 30,729 shares of the company’s stock, valued at approximately $3,880,000. TrinityBridge Ltd owned 0.86% of ChronoScale Corporation Common Stock at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of CHRN. Shay Capital LLC bought a new position in shares of ChronoScale Corporation Common Stock in the third quarter valued at about $67,000. Virtu Financial LLC bought a new stake in shares of ChronoScale Corporation Common Stock during the 3rd quarter worth about $57,000. Citadel Advisors LLC acquired a new position in ChronoScale Corporation Common Stock in the 3rd quarter valued at about $198,000. Geode Capital Management LLC grew its stake in ChronoScale Corporation Common Stock by 68.9% in the 4th quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock valued at $218,000 after buying an additional 10,281 shares during the last quarter. Finally, Roble Belko & Company Inc raised its holdings in ChronoScale Corporation Common Stock by 104.5% in the 1st quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock valued at $25,000 after acquiring an additional 1,195 shares during the period. 6.42% of the stock is currently owned by institutional investors and hedge funds.

ChronoScale Corporation Common Stock Trading Up 1.7%

Shares of CHRN stock opened at $24.10 on Friday. The firm has a 50 day moving average price of $21.82 and a two-hundred day moving average price of $15.69. The company has a quick ratio of 1.03, a current ratio of 1.55 and a debt-to-equity ratio of 0.25. The company has a market capitalization of $85.80 million, a PE ratio of -4.48 and a beta of 1.00. ChronoScale Corporation Common Stock has a 12-month low of $3.23 and a 12-month high of $30.00.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last posted its earnings results on Tuesday, June 30th. The company reported ($3.89) EPS for the quarter. The firm had revenue of $18.09 million during the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. As a group, analysts predict that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current year.

ChronoScale Corporation Common Stock Profile

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.